IXHL Stock Analysis: Buy, Sell, or Hold?
IXHL - Incannex Healthcare Limited American Depositary Shares
$3.06
0.01 (0.33%)
▲
5d:
-5.85%
30d:
-33.77%
90d:
-22.73%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When IXHL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IXHL shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: IXHL shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.53
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.06
24.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IXHL is currently trading at $3.06, which is considered oversold relative to its 30-day fair value range of $3.38 to $4.47. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.4) compared to its historical average (3.7). Remarkably, the market is currently pricing in an annual earnings decline of 13.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IXHL is in a strong uptrend. The price is currently testing key support at $3.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IXHL is in a strong uptrend. The price is currently testing key support at $3.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.38 -
$4.47
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- CAUTION: Recommendation downgraded due to -5.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.38 -
$4.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.00
Resistance Level
$3.79
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.43
Revenue Growth (YoY)
-100.0%
Valuation Discount vs History
-13.3% cheaper
PE vs Historical
2.4 vs 3.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.3%
(market-implied from PE analysis)
1-Year Target
$2.75
(-10%)
2-Year Target
$2.48
(-19%)
3-Year Target
$2.23
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→4)
$3.40
(+11%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.4 to 3.7
Stabilization Target:
$4.66
(+52.4%)
PE Expansion Potential:
+52.4%
Share & Embed Analysis
Last updated: June 03, 2026 7:27 PM ET
Data refreshes hourly during market hours. Next update: 8:27 PM
Data refreshes hourly during market hours. Next update: 8:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IXHL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 55 HOLD |
